Differentiation-dependent changes in human trophoblast expression of decay-accelerating factor are modulated by 3',5' cyclic adenosine monophosphate

Journal of the Society for Gynecologic Investigation

Volumn 4, Issue 1, 1997, Pages 47-53

  Zarkadis, I K ^b   Omigbodun, A ^b   Forson, A ^b   Ziolkiewicz, P ^b   Kinoshita, T ^b   Lambris, J D ^b   Coutifaris, C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Cell lysis; complement; cyclic AMP; differentiation; RNA splicing

Indexed keywords

CYCLIC AMP; DECAY ACCELERATING FACTOR;

ARTICLE; CELL DIFFERENTIATION; CYTOLYSIS; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TROPHOBLAST;

ANTIGENS, CD55; BLOTTING, NORTHERN; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP; HISTOCYTOCHEMISTRY; HUMANS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TROPHOBLASTS;

EID: 0031049568     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(96)00061-5     Document Type: Article

References (29)

1. 1. Benirschke K, Kaufman P. Pathology of the human placenta, 2nd ed. New York; Springer-Verlag, 1990:13-21.
2. 2. Davies M, Browne CM. Anti-trophoblast antibody responses during normal human pregnancy. J Reprod Immunol 1985;7: 285-97.
3. 3. Holmes CH, Simpson KL, Wainwright SD, et al. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 1990;144:3099-105.
4. 4. Hsi B-L, Hunt JS, Atkinson JP. Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells. J Reprod Immunol 1991;19:209-23.
5. 5. Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 1993;151:1562-70.
6. 6. Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW, Nussenzweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 1987;325:545-9.
7. 7. Nicholson-Weller A, Burge J, Fearon DT, Weller PF, Austen KF. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 1982;129:184-9.
8. 8. Cunningham DS, Tichenor JR Jr. Decay-accelerating factor protects human trophoblast from complement-mediated attack. Clin Immunol Immunopathol 1995;74:156-61.
9. 9. Holmes CH, Simpson KL, Okada H, et al. Complement regulatory proteins at the feto-maternal interface during human placental development: Distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992;22:1579-85.
10. 10. Nishikori K, Noma J, Hirakawa S, Amano T, Kudo T. The change of membrane complement regulatory protein in chorion of early pregnancy. Clin Immunol Immunopathol 1993;69:167-74.
11. 11. Hill JA, Melling GC, Johnson PM. Immunohistochemical studies of human uteroplacental tissues from first-trimester spontaneous abortion. Am J Obstet Gynecol 1995;173:90-6.
12. 12. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118:1567-82.
13. 13. Babalola GO, Coutifaris C, Soto EA, Kliman HJ, Shuman H, Strauss JF III. Aggregation of dispersed human cytotrophoblastic cells: Lessons relevant to the morphogenesis of the placenta. Dev Biol 1990;137:100-8.
14. 14. Coutifaris C, Babalola GO, Abisogun AO, et al. In vitro systems for the study of human trophoblast implantation. Ann NY Acad Sci 1991;622:191-201.
15. 15. Thomas DJ, Lublin DM. Identification of 5′-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. J Immunol 1993; 150:151-60.
16. 16. Kao L-C, Babalola GO, Kopf GS, Coutifaris CS, Strauss III JF. Differentiation of human trophoblasts: Structure-function relationships. In: Leung PCK, Hsueh AJW, Friesen HG, eds. Molecular basis of reproductive endocrinology. New York: Springer-Verlag, 1993:159-70.
17. 17. Kinoshita T, Medof ME, Silber R, Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobin-uria. J Exp Med 1985;162:75-92.
18. 18. Sambrook J, Fritsch EG, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Plainview, New York: Cold Spring Harbor Laboratory Press, 1989:719-25, 739-52.
19. 19. Medof ME, Lublin DM, Holers VM, et al. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 1987;84:2007-11.
20. 20. Ringler GE, Strauss III JF. In vitro systems for the study of human placental endocrine function. Endocr Rev 1990;11:105-23.
21. 21. Hasty LA, Lambris JD, Lessey BA, Pruksananonda K, Lyttle CR. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol 1994;170: 168-75.
22. 22. Smith CWJ, Patton JG, Nadal-Ginard B. Alternative splicing in the control of gene expression. Annu Rev Genet 1989;23:527-77.
23. 23. Maniatis T. Mechanisms of alternative pre-mRNA splicing. Science 1991;251:33-4.
24. 24. Erneux C, Van Sande J, Jastorff B, Dumont JE. Modulation of cyclic AMP action in the dog thyroid by its agonist and antagonist Sp- and Rp-adenosine 3′,5′-monophosphorothioate. Biochem J 1986;234:193-7.
25. 25. Kozak M. Regulation of protein synthesis in virus infected animal cells. Adv Virus Res 1986;31:229-92.
26. 26. Brawerman G. Determinants of messenger RNA stability. Cell 1987;48:5-6.
27. 27. Gil G, Smith JR, Goldstein JL, Brown MS. Optional exon in the 5′-untranslated region of 3-hydroxy-3-methylglutaryl coenzyme A synthase gene: Conserved sequence and splicing pattern in humans and hamsters. Proc Natl Acad Sci USA 1987;84: 1863-6.
28. 28. Ladner MB, Martin GA, Noble JA, et al. Human CSF-1: Gene structure and alternative splicing of mRNA precursors. EMBO J 1987;6:2693-8.
29. 29. Levy JR, Hannah S, Mooney RL, Hug V, Stevens W. Sequence and functional characterization of the terminal exon of the human insulin receptor gene. Biochim Biophys Acta 1995;1263: 253-7.